Apoptosis in heart transplantation

Coronary Artery Disease

Volumn 8, Issue 10, 1997, Pages 617-621

  Shaddy, Robert E ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Heart transplantation

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL TISSUE; APOPTOSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GRAFT REJECTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE PACING; HUMAN; HYPERTENSION; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SHORT SURVEY;

EID: 0031472714     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199710000-00004     Document Type: Short Survey

References (28)

1. Steller H: Mechanisms and genes of cellular suicide. Science 1995, •• 267:1445-1449. An excellent review of the mechanisms and genes involved with apoptosis. The author demonstrates conservation of these properties through worms, insects and vertebrates.
2. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated • with endogenous endonuclease activation. Nature 1980, 284:555-556. One of the first descriptions of programmed cell death in thymocytes treated with methylprednisolone. The author describes characteristic structural changes of apoptosis.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of •• disease. Science 1995, 267:1456-1462. An excellent review of the role of apoptosis in a large number of human diseases. This review also discusses the possible therapeutic potential of apoptosis.
4. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
5. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994, 94:1621-1628.
6. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, et al.: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994, 75:426-433.
7. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, et al.: Stretch-induced programmed myocyte cell death. J Clin Invest 1995, 96:2247-2259.
8. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al.: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 7:86-107.
9. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S: Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996, 148:141-149.
10. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, et al.: Myocyte nuclear mitotic division and programmed cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995, 73:771-787.
11. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, et al.: Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996, 97:2891-2897.
12. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G: Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1995, 335:1190-1196.
13. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al.: • Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996, 335:1182-1189. Apoptosis was demonstrated in explanted hearts with either dilated or ischemic cardiomyopathy. The authors speculate that loss of myocytes due to apoptosis may contribute to progressive myocardial dysfunction.
14. Ino T, Nishimoto K, Okubo M, Akimoto K, Yabuta K, Kawai S, et al.: Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol 1997, 79:1137-1141.
15. Laine J, Etelmaki P, Holmberg C, Dunkel L: Apoptotic cell death in human chronic renal allograft rejection. Transplantation 1997, 63:101-105.
16. Ito H, Kasagi N, Shomori K, Osaki M, Adachi H: Apoptosis in the human allografted kidney. Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Transplantation 1995, 60:794-798.
17. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R, Martinez OM: Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995, 59:621-625.
18. Larsen CP, Alexandre DZ, Hendrix R, Ritchie SC, Pearson SC: • Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995, 60:221-224. This may be the first description of the presence of Fas and Fas ligand in the transplanted heart. Perhaps more importantly, this study demonstrates that Fas/Fas ligand interactions are not essential mediators of post-transplant graft dysfunction.
19. White WL, Zhang L, Shelby J, Trautman MS, Perkins SL, Hammond EH, • et al.: Myocardial apoptosis in a murine heterotropic murine heart transplant model of chronic rejection and graft vasculopathy. J Heart Lung Transplant 1997, 16:250-255. This study demonstrates evidence of Fas ligand and apoptosis in both murine allografts and syngeneic grafts. As both allografts and syngeneic grafts show evidence of apoptosis, but only allografts strongly express the Fas ligand, different mechanisms may account for apoptosis in these two models.
20. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et al.: Expression of Fas ligand in cells of T cell lineage. J Immunol 1995, 154:3806-3813.
21. Bergese SD, Klenotic SM, Wakely ME, Sedmak DD, Oroscz CG: • Apoptosis in murine cardiac grafts. Transplantation 1997, 63:320-325. Whereas these investigators found apoptosis in the transplanted murine heart, apoptosis did not correlate with graft failure or parenchymal cell damage. The authors speculated that the periarterial apoptosis seen in this study may be indicative of immunoregulatory processes or repair processes of the graft.
22. Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, et al.: Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthesis. Circulation 1996, 94:1665-1673.
23. Laguens RP, Meckert PMC, San Martino J, Perrone S, Favarola R: Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996, 15:911-918.
24. Jollow KC, Sunderstrom JB, Gravanis MB, Kanter K, Herskowitz A, • Ansari AA: Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells. Transplantation 1997, 63:1482-1489. These investigators examined human allograft biopsy specimens and found apoptosis in the Quilty lesions of rejecting hearts, but not in the Quilty lesions of nonrejecting hearts. The authors give a word of caution in the interpretation of data regarding mononuclear cells that are cultured and propagated from biopsy specimens.
25. Grasl-Kraup B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, • Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL) assay fails to discriminate among apoptosis, necrosis and autolytic cell death: a cautionary note. Hepatology 1995, 21:1465-1468. The investigators demonstrate that DNA fragmentation is common to different kinds of cell death and that its detection should not be considered a specific marker of apoptosis.
26. Bellamy COC, Malcolmson RDG, Harrison DJ, Wyllie AH: Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 1995, 6:3-16.
27. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis In human atherogenesis and in a rat vascular injury model. Am J Pathol 1995, 147:267-277.
28. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995, 95:2266-2274.